INSYS Therapeutics Inc
45 clinical trials · Sponsor
◉ Watch INSYS Therapeutics Inc
| Record | Firm | Date |
|---|---|---|
| A Study to Compare Bioavailability of Naloxone Nasal Spray, Naloxone Hydrochloride (HCl) Intravenous (IV) and Intramuscular Injection (IM) in Healthy Volunteers (NCT03827642) | INSYS Therapeutics Inc | 2018-04-23 |
| Fentanyl Sublingual Spray for the Treatment of Acute Procedure-related Pain in a Monitored Setting (NCT02138409) | INSYS Therapeutics Inc | 2017-12-30 |
| Cannabidiol Oral Solution as an Adjunctive Therapy for Treatment of Participants With Inadequately Controlled Dravet Syndrome (NCT02318563) | INSYS Therapeutics Inc | 2017-12-30 |
| Cannabidiol Oral Solution as an Adjunctive Therapy for Treatment of Participants With Inadequately Controlled Lennox-Gastaut Syndrome (NCT02318537) | INSYS Therapeutics Inc | 2017-12-30 |
| Study of Buprenorphine Sublingual Spray Versus Standard of Care Narcotic Therapy for the Treatment of Post-Operative Pain (NCT03254459) | INSYS Therapeutics Inc | 2017-09-12 |
Track INSYS Therapeutics Inc automatically
Every clearance here is in the API, with alerts when new ones post.